• Company
• New colorectal cancer drug Braftovi will receive reimb
• by Jan 12, 2024 07:05am

• Company
• Nexviazyme prescriptions are available at general hospitals
• by Eo, Yun-Ho Jan 12, 2024 07:05am

• Policy
• Enhertu’s reimb to be redeliberated at next DREC meeting
• by Lee, Tak-Sun Jan 12, 2024 07:05am

• Company
• FDA approves BLA for Dong-A ST’s Stelara biosimilar
• by Chon, Seung-Hyun Jan 11, 2024 05:45am

• Company
• Dong-A ST signs MOU with Israel’s Eleven Therapeutics
• by Son, Hyung-Min Jan 11, 2024 05:45am

• Company
• 5th JAK inhibitor Jyseleca lands in general hospitals in KOR
• by Eo, Yun-Ho Jan 11, 2024 05:45am

• Opinion
• [Reporter's View] GOV takes measures to stabilize supply
• by Lee, Hye-Kyung Jan 11, 2024 05:45am

• Policy
• HIRA establishes new Pharmaceutical Benefits Dept
• by Lee, Tak-Sun Jan 11, 2024 05:44am

• Policy
• MFDS to resolve production of chemotherapy drug '5-FU'
• by Lee, Hye-Kyung Jan 10, 2024 05:42am

• Product
• Saxenda’s shortage prolonged…raises inconveniences
• by Kang, Hye-Kyung Jan 10, 2024 05:42am